Rare Disease Diagnostics Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Rare Disease Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.0% during the forecast period.
This report presents the market size and development trends by detailing the Rare Disease Diagnostics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Rare Disease Diagnostics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Rare Disease Diagnostics industry and will help you to build a panoramic view of the industrial development.
Rare Disease Diagnostics Market, By Type:
Genetic Tests
General Lab Tests
Imaging
Others
Rare Disease Diagnostics Market, By Application:
Hospital Laboratories
Diagnostic Laboratory
Genetic Testing Laboratories
Cancer Research Laboratories
Others
Some of the leading players are as follows:
Strand Life Sciences Pvt Ltd.
Illumina Inc.
23andMe, Inc.
BGI, Partek, Inc.
3billion, Inc.
Laboratory Corporation of America
Laboratory Corporation of America
QIAGEN N.V.
Eurofins Scientific
Retrophin, Inc.
GENEWIZ
Centogene A.G.
PerkinElmer, Inc.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Rare Disease Diagnostics Market: Technology Type Analysis
-
4.1 Rare Disease Diagnostics Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Rare Disease Diagnostics Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Genetic Tests
4.3.2 General Lab Tests
4.3.3 Imaging
4.3.4 Others
5 Rare Disease Diagnostics Market: Product Analysis
-
5.1 Rare Disease Diagnostics Product Market Share Analysis, 2018 & 2026
-
5.2 Rare Disease Diagnostics Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Rare Disease Diagnostics Market: Application Analysis
-
6.1 Rare Disease Diagnostics Application Market Share Analysis, 2018 & 2026
-
6.2 Rare Disease Diagnostics Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital Laboratories
6.3.2 Diagnostic Laboratory
6.3.3 Genetic Testing Laboratories
6.3.4 Cancer Research Laboratories
6.3.5 Others
7 Rare Disease Diagnostics Market: Regional Analysis
-
7.1 Rare Disease Diagnostics Regional Market Share Analysis, 2018 & 2026
-
7.2 Rare Disease Diagnostics Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Strand Life Sciences Pvt Ltd.
9.1.1 Strand Life Sciences Pvt Ltd. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Illumina Inc.
9.2.1 Illumina Inc. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 23andMe, Inc.
9.3.1 23andMe, Inc. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 BGI, Partek, Inc.
9.4.1 BGI, Partek, Inc. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 3billion, Inc.
9.5.1 3billion, Inc. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Laboratory Corporation of America
9.6.1 Laboratory Corporation of America Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Laboratory Corporation of America
9.7.1 Laboratory Corporation of America Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 QIAGEN N.V.
9.8.1 QIAGEN N.V. Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Eurofins Scientific
9.9.1 Eurofins Scientific Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Retrophin, Inc.
9.10.1 Retrophin, Inc. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 GENEWIZ
9.11.1 GENEWIZ Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Centogene A.G.
9.12.1 Centogene A.G. Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 PerkinElmer, Inc.
9.13.1 PerkinElmer, Inc. Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
The List of Tables and Figures (Totals 95 Figures and 143 Tables)
Figure Genetic Tests Rare Disease Diagnostics market, 2015 - 2026 (USD Million)
Figure General Lab Tests Rare Disease Diagnostics market, 2015 - 2026 (USD Million)
Figure Imaging Rare Disease Diagnostics market, 2015 - 2026 (USD Million)
Figure Others Rare Disease Diagnostics market, 2015 - 2026 (USD Million)
Figure Hospital Laboratories market, 2015 - 2026 (USD Million)
Figure Diagnostic Laboratory market, 2015 - 2026 (USD Million)
Figure Genetic Testing Laboratories market, 2015 - 2026 (USD Million)
Figure Cancer Research Laboratories market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Rare Disease Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table North America Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table North America Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table North America Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Canada Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Canada Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Europe Rare Disease Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Europe Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Europe Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Europe Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Germany Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Germany Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table France Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table France Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Italy Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Italy Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Spain Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Spain Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Rare Disease Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table China Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table China Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Japan Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Japan Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table India Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table India Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Rare Disease Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table MEA Rare Disease Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table MEA Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table MEA Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table MEA Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Rare Disease Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Rare Disease Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Rare Disease Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Strand Life Sciences Pvt Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Illumina Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table 23andMe, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BGI, Partek, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table 3billion, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Laboratory Corporation of America Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Laboratory Corporation of America Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table QIAGEN N.V. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eurofins Scientific Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Retrophin, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GENEWIZ Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Centogene A.G. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PerkinElmer, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Report Purchase
